CHAMPIONS ONCOLOGY, INC. (CSBR) Net margin 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) net profit margin by fiscal year — reported net income divided by reported revenue.
-2.0%FY2026 · since FY2018: -7.3% → -2.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -2.0% | -10.2 pp |
| FY2025 | 8.3% | +22.8 pp |
| FY2024 | -14.5% | -4.6 pp |
| FY2023 | -9.9% | -11.0 pp |
| FY2022 | 1.1% | +0.2 pp |
| FY2021 | 0.9% | +7.4 pp |
| FY2020 | -6.5% | -7.0 pp |
| FY2019 | 0.5% | +7.8 pp |
| FY2018 | -7.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice